» Articles » PMID: 32674450

Clinical Presentation of COVID-19: Case Series and Review of the Literature

Overview
Publisher MDPI
Date 2020 Jul 18
PMID 32674450
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 infection has a broad spectrum of severity ranging from an asymptomatic form to a severe acute respiratory syndrome that requires mechanical ventilation. Starting with the description of our case series, we evaluated the clinical presentation and evolution of COVID-19. This article is addressed particularly to physicians caring for patients with COVID-19 in their clinical practice. The intent is to identify the subjects in whom the infection is most likely to evolve and the best methods of management in the early phase of infection to determine which patients should be hospitalized and which could be monitored at home. Asymptomatic patients should be followed to evaluate the appearance of symptoms. Patients with mild symptoms lasting more than a week, and without evidence of pneumonia, can be managed at home. Patients with evidence of pulmonary involvement, especially in patients over 60 years of age, and/or with a comorbidity, and/or with the presence of severe extrapulmonary manifestations, should be admitted to a hospital for careful clinical-laboratory monitoring.

Citing Articles

Using Association Rules to Obtain Sets of Prevalent Symptoms throughout the COVID-19 Pandemic: An Analysis of Similarities between Cases of COVID-19 and Unspecified SARS in São Paulo-Brazil.

Marques J, Carvalho B, Guedes L, Da Costa-Abreu M Int J Environ Res Public Health. 2024; 21(9).

PMID: 39338047 PMC: 11430988. DOI: 10.3390/ijerph21091164.


Recent and advanced nano-technological strategies for COVID-19 vaccine development.

Nwagwu C, Ugwu C, Ogbonna J, Onugwu A, Agbo C, Echezona A Methods Microbiol. 2024; 50:151-188.

PMID: 38620863 PMC: 9015106. DOI: 10.1016/bs.mim.2022.03.001.


The use of and , two Ghanaian herbal medicines in the management of mild COVID-19: A case report.

Boakye-Yiadom M, Yeboah R, Offei-Abrokwa D, Wilson E, Darko S, Tamakloe E Clin Case Rep. 2024; 12(2):e8539.

PMID: 38405358 PMC: 10890966. DOI: 10.1002/ccr3.8539.


Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran.

Babaei M, Heidari B, Ghorbani H, Ahmadnia Z, Rouhi S, Sadeghi Haddad Zavareh M Infect Disord Drug Targets. 2024; 24(6):e090224226818.

PMID: 38343046 DOI: 10.2174/0118715265209731240129042916.


Radiological Patterns of Lung Injury on HRCT in COVID-19 Patients: An Experience From Tertiary Care Centre in India.

Verma A, Mishra S, Dikshit N, Rawat A, Kumar S Cureus. 2023; 15(11):e48479.

PMID: 38073967 PMC: 10704110. DOI: 10.7759/cureus.48479.


References
1.
Ahmad I, Rathore F . Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020; 77:8-12. PMC: 7200361. DOI: 10.1016/j.jocn.2020.05.017. View

2.
Recalcati S . Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020; 34(5):e212-e213. DOI: 10.1111/jdv.16387. View

3.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

4.
Li R, Pei S, Chen B, Song Y, Zhang T, Yang W . Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020; 368(6490):489-493. PMC: 7164387. DOI: 10.1126/science.abb3221. View

5.
Sardu C, DOnofrio N, Balestrieri M, Barbieri M, Rizzo M, Messina V . Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?. Diabetes Care. 2020; 43(7):1408-1415. PMC: 7305003. DOI: 10.2337/dc20-0723. View